Page 53 - Read Online

Page 16 of 19 Hewitt et al. Hepatoma Res 2021;7:75 https://dx.doi.org/10.20517/2394-5079.2021.83

44. Ogasawara S. Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human
biliary tract carcinoma cell lines. Hepatol Res 2001;20:97-113. DOI PubMed
45. Leelawat K, Leelawat S, Tepaksorn P, et al. Involvement of c-Met/hepatocyte growth factor pathway in cholangiocarcinoma cell
invasion and its therapeutic inhibition with small interfering RNA specific for c-Met. J Surg Res 2006;136:78-84. DOI PubMed
46. Sirica AE. Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma. World J Gastroenterol 2008;14:7033-
58. DOI PubMed PMC
47. Network NCC. Hepatobiliary cancers v2.2021. https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf [Last
accessed on 15 Nov 2021].
48. Bridgewater J, Galle PR, Khan SA, et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol 2014;60:1268-89. DOI PubMed
18
18
49. Lamarca A, Barriuso J, Chander A, et al. F-fluorodeoxyglucose positron emission tomography ( FDG-PET) for patients with
biliary tract cancer: systematic review and meta-analysis. J Hepatol 2019;71:115-29. DOI PubMed
50. Masselli G, Gualdi G. Hilar cholangiocarcinoma: MRI/MRCP in staging and treatment planning. Abdom Imaging 2008;33:444-51.
DOI PubMed
51. Tsao JI, Nimura Y, Kamiya J, et al. Management of hilar cholangiocarcinoma: comparison of an American and a Japanese
experience. Ann Surg 2000;232:166-74. DOI PubMed PMC
52. Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: a comprehensive update, part 1.
Oncology (Williston Park) 2004;18:889-96. PubMed
53. Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar
cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 2003;238:720-7. DOI PubMed PMC
54. Hemming AW, Reed AI, Fujita S, Foley DP, Howard RJ. Surgical management of hilar cholangiocarcinoma. Ann Surg
2005;241:693-9; discussion 699-702. DOI PubMed PMC
55. Mizuno T, Ebata T, Yokoyama Y, et al. Combined vascular resection for locally advanced perihilar cholangiocarcinoma. Ann Surg
2020. DOI PubMed
56. Sano T, Shimizu Y, Senda Y, Kinoshita T, Nimura Y. Assessing resectability in cholangiocarcinoma. Hepat Oncol 2014;1:39-51.
DOI PubMed PMC
57. Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement.
HPB (Oxford) 2015;17:691-9. DOI PubMed PMC
58. Liu F, Li Y, Wei Y, Li B. Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? Dig Dis Sci
2011;56:663-72. DOI PubMed
59. Mehrabi A, Khajeh E, Ghamarnejad O, et al. Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing
liver resection for perihilar cholangiocarcinoma. Eur J Radiol 2020;125:108897. DOI PubMed
60. Laurent A, Tayar C, Cherqui D. Cholangiocarcinoma: preoperative biliary drainage (Con). HPB (Oxford) 2008;10:126-9. DOI
PubMed PMC
61. Nimura Y. Preoperative biliary drainage before resection for cholangiocarcinoma (Pro). HPB (Oxford) 2008;10:130-3. DOI PubMed
PMC
62. Moole H, Bechtold M, Puli SR. Efficacy of preoperative biliary drainage in malignant obstructive jaundice: a meta-analysis and
systematic review. World J Surg Oncol 2016;14:182. DOI PubMed PMC
63. Scheufele F, Schorn S, Demir IE, et al. Preoperative biliary stenting versus operation first in jaundiced patients due to malignant
lesions in the pancreatic head: a meta-analysis of current literature. Surgery 2017;161:939-50. DOI PubMed
64. Iacono C, Ruzzenente A, Campagnaro T, Bortolasi L, Valdegamberi A, Guglielmi A. Role of preoperative biliary drainage in
jaundiced patients who are candidates for pancreatoduodenectomy or hepatic resection: highlights and drawbacks. Ann Surg
2013;257:191-204. DOI PubMed
65. Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European
Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - updated October 2017. Endoscopy 2018;50:910-30. DOI
PubMed
66. Paik WH, Loganathan N, Hwang JH. Preoperative biliary drainage in hilar cholangiocarcinoma: when and how? World J Gastrointest
Endosc 2014;6:68-73. DOI PubMed PMC
67. Hameed A, Pang T, Chiou J, et al. Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a
systematic review and meta-analysis. HPB (Oxford) 2016;18:400-10. DOI PubMed PMC
68. Al Mahjoub A, Menahem B, Fohlen A, et al. Preoperative biliary drainage in patients with resectable perihilar cholangiocarcinoma: is
percutaneous transhepatic biliary drainage safer and more effective than endoscopic biliary drainage? J Vasc Interv Radiol
2017;28:576-82. DOI PubMed
69. Coelen RJS, Roos E, Wiggers JK, et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar
cholangiocarcinoma: a multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol 2018;3:681-90. DOI PubMed
70. Hwang S, Ha TY, Song GW, et al. Quantified risk assessment for major hepatectomy via the indocyanine green clearance rate and
liver volumetry combined with standard liver volume. J Gastrointest Surg 2015;19:1305-14. DOI PubMed
71. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver
tumors. Ann Surg 2000;232:777-85. DOI PubMed PMC
72. Lam VW, Laurence JM, Johnston E, Hollands MJ, Pleass HC, Richardson AJ. A systematic review of two-stage hepatectomy in
patients with initially unresectable colorectal liver metastases. HPB (Oxford) 2013;15:483-91. DOI PubMed PMC